Key points are not available for this paper at this time.
BACKGROUND AND PURPOSES: Patellofemoral pain syndrome (PFPS) is a prevalent condition among physically active females and is often associated with reduced hip and knee muscle strength, altered biomechanics, and pain-related disability. Weight-bearing exercise programs may enhance neuromuscular control and functional outcomes, but their effects on multiple objective and subjective measures have not been comprehensively studied in this population. Therefore, the main purpose of this study was to investigate the effect of the weight-bearing exercise for better balance (WEBB) program on isokinetic hip and knee muscle strength, pain intensity, pain sensitivity, and disability in females with PFPS. METHODS: A randomized controlled trial (RCT) was conducted on 30 females with clinically diagnosed PFPS. Participants were randomly allocated to either an experimental group (n = 15), receiving 8 weeks of a supervised WEBB program, or a control group (n = 15), did not receive any intervention. Outcomes included nine dependent variables: isokinetic peak torque of hip and knee muscles (flexors, extensors, abductors, adductors, knee flexors, knee extensors) measured by Biodex Isokinetic Dynamometer, pain intensity evaluated by Visual Analogue Scale (VAS), pressure pain threshold (PPT) measured by digital algometer, and disability assessed by Oswestry Disability Index (ODI). Measurements were taken at baseline and after 8 weeks of the WEBB program. RESULTS: Within the experimental group, significant improvements were observed after performing the WEBB program across all nine measured outcomes (p 0.05). DISCUSSION: The introduced WEBB program demonstrated significant within-group improvements in all measures of muscular strength, pain, and disability in females with PFPS. While between-group differences were evident in some outcomes, further studies are warranted to explore the long-term and differential effects on specific muscle groups and functional indices. TRIAL REGISTRATION: The study was registered at https://clinicaltrials.gov/.
Abdelmohsen et al. (Mon,) studied this question.